WCMOH · Registering as Listener

World Conference on Medical Oncology & Haematology

2nd Feb – 3rd Feb 2027 Herning, Denmark Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceWCMOH
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

World Conference on Medical Oncology & Haematology conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 16 - Peace, Justice and Strong Institutions

This track will explore the latest research on cancer biomarkers, focusing on their role in early diagnosis and personalized treatment strategies. Discussions will include innovative methodologies for biomarker discovery and validation.

This session will highlight cutting-edge therapeutic approaches in oncology, including monoclonal antibodies and targeted therapies. Participants will examine the efficacy and safety of these treatments in various cancer types.

This track will address the ethical dilemmas faced in oncology, including end-of-life care and informed consent. Experts will discuss the implications of emerging technologies on patient autonomy and decision-making.

This session will focus on the latest advancements in surgical techniques for cancer treatment, including minimally invasive procedures and robotic surgery. The impact of these innovations on patient outcomes will be critically evaluated.

This track will delve into the role of molecular diagnostics in tailoring cancer therapies to individual patients. Discussions will include the integration of genomic data into clinical practice and its implications for treatment efficacy.

This session will address the unique challenges faced in the diagnosis and treatment of pediatric cancers. Participants will explore innovative approaches and recent advancements in this specialized field.

This track will focus on the latest findings in cancer epidemiology, emphasizing risk factors and prevention strategies. Discussions will include public health initiatives aimed at reducing cancer incidence.

This session will explore the role of interventional techniques in the management of cancer, including ablation and embolization. The effectiveness and safety of these procedures will be critically assessed.

This track will highlight advancements in radiation therapy, including stereotactic techniques and novel radiopharmaceuticals. Participants will discuss the implications of these innovations on treatment outcomes.

This session will examine the role of nursing in oncology care, focusing on integrative approaches to support patient well-being. Discussions will include the importance of holistic care in cancer treatment.

This track will focus on the latest research and treatment strategies for hematologic malignancies, including leukemia and lymphoma. Participants will discuss novel therapies and their impact on patient management.

COPYRIGHT © 2026 World Conference on Medical Oncology & Haematology. ALL RIGHTS RESERVED